Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia. [electronic resource]
Producer: 20140114Description: e60562 p. digitalISSN:- 1932-6203
- Aged
- Biomarkers, Tumor -- genetics
- CD4-Positive T-Lymphocytes -- metabolism
- Cryopreservation
- Humans
- Immunohistochemistry
- Macrophages -- metabolism
- Male
- Middle Aged
- Nanotechnology -- methods
- Neutrophils -- metabolism
- Peroxiredoxins -- genetics
- Prostate -- metabolism
- Prostatectomy
- Prostatic Hyperplasia -- diagnosis
- Prostatic Neoplasms -- diagnosis
- Protein Binding
- Staining and Labeling
- Stromal Cells -- metabolism
- Thioredoxin Reductase 1 -- genetics
- Thioredoxin Reductase 2 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.